Impact of the COVID-19 pandemic on the seasonality of respiratory syncytial viral infection
https://doi.org/10.22625/2072-6732-2022-14-2-39-46
Abstract
The article presents an overview of current trends in the epidemiology of respiratory syncytial viral (RSV) infection, including its seasonality, under the impact of the COVID-19 pandemic, both according to world literature and taking into account monitoring epidemiological studies conducted in the Russian Federation. A detailed description of the dynamics of RSV detection in the period 2020-2021 and the beginning of 2022 in Russia according to the results of the all-Russian epidemiological monitoring is given. Epidemiological studies in different regions of the world, including Russia, have revealed the absence of seasonal rises in the incidence of RSV infection, characteristic of previous years, in 2020 and winter-spring in 2021 under the influence of the COVID-19 pandemic. In 2021-2022, a sharp increase in the incidence and hospitalization of children was noted against the back-drop of a decrease in cases of a new coronavirus infection in all countries of the world, while the start time and duration of respiratory syncytial virus infection, typical for the prepandemic period, changed. Our previous studies have shown that in different years and in different regions of Russia, the start and end times of the epidemiological season may also not coincide, which makes it difficult to predict seasonal peaks in incidence, their duration and severity only on the basis of previously obtained data. This makes it expedient to extend the terms of passive specific prophylaxis with palivizumab for a year if there are indications for its use, including taking into account the data of epidemiological monitoring conducted in the Russian Federation.
About the Authors
I. V. Babachenko
Pediatric Research and Clinical Center for Infectious Diseases; Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
E. D. Orlova
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
Russian Federation
Saint-Petersburg
Yu. V. Lobzin
Pediatric Research and Clinical Center for Infectious Diseases; North-Western State Medical University named after I.I. Mechnikov; Military Medical Academy named after S.M. Kirov
Russian Federation
Russian Federation
Saint-Petersburg
References
1. WHO strategy to pilot global respiratory syncytial virus surveillance based on the Global Influenza Surveillance and Response System (GISRS). World Health Organization. 2017. Accessed July 27, 2020. https://www.who.int/influenza/rsv/WHO_RSV_pilot_strategy_21112017.pdf
2. Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017; 390(10098): 946-958 https://www.ncbi.nlm.nih.gov/pubmed/28689664, accessed 16 November 2017.
3. Tsybalova, L.M. Lechashchiy vrach.2015; 4: 2–7 (in Russian).
4. Rovniy, V.B. Zhurnal infektologii. 2013; 5 (2): 76-81(in Russian).
5. Babachenko, I.V. Zhurnal infektologii. 2018; 10 (1): 113-120 (in Russian).
6. Babachenko, I.V. Zhurnal infektologii. 2018; 10 (3): 70-76 (in Russian).
7. Ovsyannikov, D.Yu. Zhurnal infektologii. 2019; 11(4): 99-107(in Russian).
8. Mattia G, et al. During the COVIDó19 pandemic where has respiratory syncytial virus gone? Pediatric Pulmonology. 2021 Oct; 56(10):3106-3109. DOI: 10.1002/ppul.25582
9. Williams TC, Sinha I., Barr IG, Zambon M. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic. Eurosurveillance. 2021; 26(29): 1-9. https://doi.org/10.2807/1560-917.ES.2021.26.29.2100186
10. Taylor A, Whittaker E. The Changing Epidemiology of Respiratory Viruses in Children During the COVID-19 Pandemic: A Canary in a COVID Time. The Pediatric Infectious Disease Journal. 2022; 41(2): 46-48. DOI: 10.1097/INF.0000000000003396
11. Britton PN, et al. COVID-19 public health measures and respiratory syncytial virus. The Lancet Child&Adolescent Health. 2020; 4 (11): 42-43. https://doi.org/10.1016/S2352-4642(20)30307-2
12. Trenholme A, et al. COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020. Emerging Infectious Diseases. 2021; 27 (2): 641–643. https://doi.org/10.3201/eid2702.204041
13. Kim JH, et al. Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020–2021 season of COVID-19. International Journal of Infectious Diseases. 2021; 110: 29–35. https://doi.org/10.1016/j.ijid.2021.07.005
14. Brusselen Van D, et al. Bronchiolitis in COVID-19 times: a nearly absent disease. European Journal of Pediatrics. 2021; 180: 1969-1973. https://doi.org/10.1007/s00431-021-03968-6
15. Casalegno JS, et al. Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhóne Loire, France. Eurosurveillance. 2021; 26 (29): 1-4. https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100630
16. Fourgeaud J, et al. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France. European Journal of Clinical Microbiology & Infectious Diseases. 2021; 40: 2389–2395. https://doi.org/10.1007/s10096-021-04323-1
17. Foley DA, Yeoh DK, Minney-Smith CA, et al. The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019–Related Public Health Measures. – Clin Infect Dis. 2021 Nov 2;73(9):e2829-e2830. https://doi.org/10.1093/cid/ciaa1906
18. Ujiie M., Tsuzuki S., Nakamoto T., Iwamoto N. Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan. Emerging Infectious Diseases. 2021; 27 (11): 2969-2970. https://doi.org/10.3201/eid2711.211565
19. Halabi KC, Saiman L, Zachariah P. The Epidemiology of Respiratory Syncytial Virus in New York City during the Coronavirus Disease-2019 Pandemic Compared with Previous Years. The Journal of Pediatrics. 2022; 242: 242-244. https://doi.org/10.1016/j.jpeds.2021.10.057
20. Agha R, Avner JR. Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic. Pediatrics. 2021; 148 (3): 1-3. https://doi.org/10.1542/peds.2021-052089
21. Como E, et al. Respiratory Syncytial Virus Infections in Young Children Presenting to Primary Care in Catalonia During the COVID-19 Pandemic. International Journal of Infectious Diseases. 2022, 11(2): 69–72. https://doi.org/10.1093/jpids/piab121
22. Summeren van J, et al. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Eurosurveillance. 2021; 26 (29): 1-6. https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100639
23. Binns E, et al. Influenza and respiratory syncytial virus during the COVIDó19 pandemic: Time for a new paradigm? Pediatric Pulmonology. 2022; 57: 38-42. DOI: 10.1002/ppul.25719.
24. Yezhenedel’nyy natsional’nyy byulleten’ po grippu i ORVI (in Russian). https://www.influenza.spb.ru/system/epidemic_situation/laboratory_diagnostics/?year=2022&week=07
25. Cheссhia PA, et al. Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: A systematic literature review and meta-analysis. Pediatr. Crit. Care Med. 2011 Sent; 12(5): 580-588
Review
For citations:
Babachenko I.V., Orlova E.D., Lobzin Yu.V. Impact of the COVID-19 pandemic on the seasonality of respiratory syncytial viral infection. Journal Infectology. 2022;14(2):39-46. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-2-39-46
Views:
684
.png)
.png)
Email this article 